Product image of Mometason Allergiespray Bei Heuschnupfen 1 A Pharma (Mometasone Furoate) supplied by GNH India

Mometason Allergiespray Bei Heuschnupfen 1 A Pharma

Active Ingredient:
Mometasone Furoate
Origin:
EU

Mometason Allergiespray Bei Heuschnupfen 1 A Pharma (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometason Allergiespray Bei Heuschnupfen 1 A Pharma, is a corticosteroid (glucocorticoid) presented as a nasal spray for nasal use. It treats allergic rhinitis and seasonal nasal allergy symptoms in adults and children.

GNH India supplies Mometason Allergiespray Bei Heuschnupfen 1 A Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

1 A Pharma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mometasone furoate nasal spray is used to manage inflammatory conditions of the nasal mucosa associated with allergic disease.

  • Allergic rhinitis: reduces nasal congestion, itching, sneezing and rhinorrhea.
  • Seasonal allergic rhinitis: alleviates inflammation caused by pollen or other seasonal allergens.
  • Hay fever: improves nasal airflow and decreases mucosal swelling.

How It Works

  • Mometasone furoate binds to intracellular glucocorticoid receptors in nasal epithelial cells, altering gene transcription. This down‑regulates pro‑inflammatory cytokines, chemokines and adhesion molecules, leading to reduced vascular permeability, edema, and leukocyte infiltration in the nasal mucosa, thereby controlling allergic inflammation.

Side Effects

Mometasone furoate nasal spray may cause local and systemic adverse reactions.

Common Side Effects

  • Nasal irritation or burning sensation.
  • Epistaxis (nosebleeds).
  • Headache.
  • Throat irritation or dryness.
  • Altered taste perception.
  • Cough.

Serious or Rare Side Effects

  • Nasal septal perforation.
  • Severe allergic reaction (anaphylaxis).
  • Vision changes or cataract formation.
  • Adrenal suppression with systemic exposure.
  • Opportunistic fungal infection of the nasal cavity.
  • Profound or persistent nosebleeds.

Precautions & Warnings

Before initiating therapy, consider the following safety measures.

  • Assess for active nasal infection: avoid use if bacterial or fungal sinusitis is present.
  • Monitor intra‑ocular pressure: caution in patients with glaucoma or ocular hypertension.
  • Limit duration of continuous use: follow prescriber guidance to reduce risk of systemic effects.
  • Use with pediatric caution: adhere to age‑specific dosing recommendations.
  • Store at room temperature: keep in the original container, protect from moisture and heat.

Avoid Interactions

Mometasone furoate nasal spray can interact with other medicines; awareness of the interaction level helps manage risk.

Major Interactions (Avoid)

  • Concurrent potent CYP3A4 inhibitors: may increase systemic corticosteroid exposure.
  • Systemic corticosteroids: additive glucocorticoid effects can raise risk of adrenal suppression.
  • Immunosuppressants: may exacerbate infection risk.

Moderate Interactions (Monitor Closely)

  • Antihistamines: may increase local irritation.
  • Decongestant nasal sprays: could affect absorption or cause rebound congestion.
  • Live vaccines: nasal corticosteroid may diminish local immune response.
  • Antifungal agents: monitor for potential fungal overgrowth in the nasal cavity.

Frequently Asked Questions

Mometason Allergiespray Bei Heuschnupfen 1 A Pharma is a nasal spray containing mometasone furoate that is prescribed to relieve symptoms of allergic rhinitis, such as nasal congestion, sneezing, itching and runny nose, especially during seasonal allergy periods.

Mometasone furoate binds to glucocorticoid receptors in the cells lining the nasal passages. This interaction modifies gene expression, suppressing the production of inflammatory cytokines and reducing swelling, mucus formation and immune cell activity that cause allergy symptoms.

The exact dosing regimen for Mometason Allergiespray is determined by the prescribing healthcare professional based on the patient’s age, severity of symptoms and clinical response. Patients should follow the prescriber’s instructions and the product label.

Safety data for mometasone furoate nasal spray in pregnancy and lactation are limited. Healthcare providers usually weigh the potential benefits against any possible risks before prescribing it to pregnant or nursing individuals.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mometason Allergiespray contains mometasone furoate, a high‑potency glucocorticoid with a favorable local anti‑inflammatory profile. Compared with lower‑potency agents such as fluticasone, it may achieve symptom control with a similar or lower dose, but individual response and tolerability can vary.

Store the nasal spray at room temperature, below 25 °C, in its original packaging. Keep it away from moisture, direct sunlight and excessive heat to maintain product stability.

The spray is applied directly into each nostril as directed by the prescriber, typically after gently shaking the bottle and priming it if required. The patient should avoid blowing the nose immediately after use to allow optimal absorption.

Serious risks, though rare, include nasal septal perforation, severe allergic reactions (anaphylaxis), adrenal suppression from systemic absorption, and opportunistic fungal infections. Patients should report any unusual bleeding, vision changes or signs of infection promptly.

Individuals with known hypersensitivity to mometasone furoate or any component of the formulation should avoid the product. It is also contraindicated in patients with active untreated nasal infections or recent nasal surgery unless advised by a clinician.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Mometasone Furoate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT